TW200613275A - Lercanidipine salts - Google Patents

Lercanidipine salts

Info

Publication number
TW200613275A
TW200613275A TW094128384A TW94128384A TW200613275A TW 200613275 A TW200613275 A TW 200613275A TW 094128384 A TW094128384 A TW 094128384A TW 94128384 A TW94128384 A TW 94128384A TW 200613275 A TW200613275 A TW 200613275A
Authority
TW
Taiwan
Prior art keywords
acids
lercanidipine
acid
salts
amorphous
Prior art date
Application number
TW094128384A
Other languages
English (en)
Inventor
Amedeo Leonardi
Gianni Motta
Raumer Markus Von
Original Assignee
Recordati Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Ireland Ltd filed Critical Recordati Ireland Ltd
Publication of TW200613275A publication Critical patent/TW200613275A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
TW094128384A 2004-08-24 2005-08-19 Lercanidipine salts TW200613275A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60414904P 2004-08-24 2004-08-24

Publications (1)

Publication Number Publication Date
TW200613275A true TW200613275A (en) 2006-05-01

Family

ID=35159792

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094128384A TW200613275A (en) 2004-08-24 2005-08-19 Lercanidipine salts

Country Status (19)

Country Link
US (1) US7683179B2 (zh)
EP (1) EP1799644B1 (zh)
JP (1) JP2008510754A (zh)
KR (1) KR20070045351A (zh)
CN (1) CN101048379A (zh)
AR (1) AR050467A1 (zh)
AU (1) AU2005276619B2 (zh)
BR (1) BRPI0514606A (zh)
CA (1) CA2575078A1 (zh)
EA (1) EA011773B1 (zh)
ES (1) ES2462921T3 (zh)
IL (1) IL180905A0 (zh)
MX (1) MX2007002141A (zh)
NO (1) NO20071515L (zh)
NZ (1) NZ553127A (zh)
PE (1) PE20060629A1 (zh)
TW (1) TW200613275A (zh)
WO (1) WO2006021397A1 (zh)
ZA (1) ZA200702364B (zh)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1953162B9 (de) * 2001-02-24 2012-10-31 Boehringer Ingelheim Pharma GmbH & Co. KG Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
AR052918A1 (es) * 2005-02-25 2007-04-11 Recordati Ireland Ltd Clorhidrato de lercanidipina amorfo
AR053023A1 (es) * 2005-02-25 2007-04-18 Recordati Ireland Ltd Base libre de lercanidipina, metodos para su preparacion y composiciones farmaceuticas que las contienen
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
AU2007247190A1 (en) 2006-05-04 2007-11-15 Boehringer Ingelheim International Gmbh Polymorphs
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
MY147013A (en) 2006-06-12 2012-10-15 Novartis Ag Process for making salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide
WO2008040367A1 (en) * 2006-08-01 2008-04-10 Union Quimico-Farmaceutica S.A. Lercanidipine hydrobromide, a process for its preparation, crystalline forms and compositions thereof
US20080175872A1 (en) * 2006-09-28 2008-07-24 Osmotica Corp. Controlled Release Dosage Form Containing Lercanidipine and a Performance-enhancing Acid
ES2306595B1 (es) * 2007-02-09 2009-09-11 Laboratorios Almirall S.A. Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2.
US20080234516A1 (en) * 2007-03-14 2008-09-25 Valerie Niddam-Hildesheim Processes for preparing solid states of O-desmethylvenlafaxine succinate
WO2009017813A1 (en) * 2007-08-02 2009-02-05 Teva Pharmaceutical Industries Ltd. O-desmethyl venlafaxine saccharinate
KR20100074303A (ko) 2007-11-26 2010-07-01 테바 파마슈티컬 인더스트리즈 리미티드 Ｏ-데스메틸벤라팍신 푸마레이트의 결정형
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
JP5674660B2 (ja) * 2008-08-01 2015-02-25 ザ メディシンズ カンパニー 医薬組成物および不純物の濃度が低い医薬組成物の製造方法
US20100105743A1 (en) * 2008-08-01 2010-04-29 Gopal Krishna Pharmaceutical compositions and methods for stabilizing the same
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
JP2012502081A (ja) 2008-09-10 2012-01-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糖尿病及び関連症状の治療のための組み合わせ治療
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CN102256976A (zh) 2008-12-23 2011-11-23 贝林格尔.英格海姆国际有限公司 有机化合物的盐形式
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
ES2760917T3 (es) 2009-11-27 2020-05-18 Boehringer Ingelheim Int Tratamiento de pacientes diabéticos genotipificados con inhibidores DPP-IV como la linagliptina
CA2795023A1 (en) * 2010-03-29 2011-10-06 Pliva Hrvatska D.O.O. Crystal forms of o-desmethylvenlafaxine fumarate
CA2797310C (en) 2010-05-05 2020-03-31 Boehringer Ingelheim International Gmbh Glp-1 receptor agonist and dpp-4 inhibitor combination therapy
EA201991014A1 (ru) 2010-06-24 2019-09-30 Бёрингер Ингельхайм Интернациональ Гмбх Лечение диабета
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
EA030121B1 (ru) 2011-07-15 2018-06-29 Бёрингер Ингельхайм Интернациональ Гмбх Замещенные хиназолины, их получение и их применение в фармацевтических композициях
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
US9526728B2 (en) 2014-02-28 2016-12-27 Boehringer Ingelheim International Gmbh Medical use of a DPP-4 inhibitor
EP4233840A3 (en) 2016-06-10 2023-10-18 Boehringer Ingelheim International GmbH Combinations of linagliptin and metformin
WO2023219106A1 (ja) * 2022-05-10 2023-11-16 Ｍｙｒｏｄｉａ Ｔｈｅｒａｐｅｕｔｉｃｓ株式会社 ２－メチル－２－チアゾリンの塩

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters
IT1275532B (it) * 1995-07-14 1997-08-07 Recordati Chem Pharm Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa
US5696139A (en) 1995-05-12 1997-12-09 Recordati S.A., Chemical And Pharmaceutical Company Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure
US5767136A (en) 1995-05-12 1998-06-16 Recordati, S.A. Chemical And Pharmaceutical Company 1,4-Dihydropyridines useful for prevention or reduction of atherosclerotic lesions on arterial walls
IT1301759B1 (it) * 1998-06-19 2000-07-07 Nicox Sa Sali nitrati di farmaci antiipertensivi
US20030069285A1 (en) 2001-08-06 2003-04-10 Recordati Ireland Limited Novel solvate and crystalline forms of lercanidipine hydrochloride
US6852737B2 (en) 2001-08-06 2005-02-08 Recordati Ireland Limited Crude and crystalline forms of lercanidipine hydrochloride
US6699892B2 (en) * 2002-06-04 2004-03-02 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salt of amlodipine and method of preparing the same
AU2003274004A1 (en) * 2002-10-16 2004-05-04 Recordati Ireland Limited Lisinopril/lercanidipine combination therapy
US20040198789A1 (en) * 2003-02-28 2004-10-07 Recordati Ireland Limited Lercanidipine/ARB/diuretic therapeutic combinations

Also Published As

Publication number Publication date
AU2005276619B2 (en) 2009-04-30
CN101048379A (zh) 2007-10-03
WO2006021397A8 (en) 2006-04-27
ES2462921T3 (es) 2014-05-26
US20060047125A1 (en) 2006-03-02
KR20070045351A (ko) 2007-05-02
EP1799644A1 (en) 2007-06-27
PE20060629A1 (es) 2006-08-11
MX2007002141A (es) 2007-04-27
CA2575078A1 (en) 2006-03-02
BRPI0514606A (pt) 2008-06-17
AU2005276619A1 (en) 2006-03-02
EP1799644B1 (en) 2014-02-12
JP2008510754A (ja) 2008-04-10
IL180905A0 (en) 2007-07-04
US7683179B2 (en) 2010-03-23
WO2006021397A1 (en) 2006-03-02
NO20071515L (no) 2007-05-22
EA011773B1 (ru) 2009-06-30
ZA200702364B (en) 2008-09-25
NZ553127A (en) 2009-07-31
AR050467A1 (es) 2006-10-25
EA200700492A1 (ru) 2007-08-31

Similar Documents

Publication Publication Date Title
TW200613275A (en) Lercanidipine salts
EA201390922A1 (ru) Сложнополиэфирные полиаминные и сложнополиэфирные поличетвертичные аммониевые ингибиторы коррозии
MY151458A (en) Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
GB0714228D0 (en) Oral compositions. Their preparation and use
BRPI0510374A (pt) processo para preparar um ácido carboxìlico alifático
SE0200730D0 (sv) Kristallin bas av citalopram
EA201070966A1 (ru) Фолаты, композиции и применение указанных композиций
NZ609340A (en) Fatty amines, amidoamines, and their derivatives from natural oil metathesis
IL181158A0 (en) Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i?á
EP1842572A3 (en) Hair cleansing composition
RU2012151152A (ru) Твердая композиция терефталевой кислоты
NO20034667L (no) Arylsulfonamider som antivirale midler
AU2003287912A1 (en) Dicarboxylic acid derivatives as ppar-agonists
WO2012001276A3 (fr) Compositions acides pour l'élimination des oxalates
DE60326007D1 (de) Inhibierung der kristallisation von kolophonium
HK1170976A1 (zh) 芳族二羧酸的優化製備
SG122932A1 (en) Compositions comprising tannic acis as corrosion inhibitor
WO2007002128A3 (en) Compositions comprising and processes for producing inorganic salts of hop acids
MA32193B1 (fr) Procede de preparation de combretastatine
ATE457324T1 (de) Beschichtungszusammensetzung
WO2007045353A3 (de) Kombinationspräparate von salzen der o-acetylsalicylsäure
NO20075364L (no) Forbedringer i eller i forbindelse med bitumenmaterialer
WO2006097809A3 (en) Novel tyrosine derivatives
JP2009067947A5 (zh)
WO2007061314A3 (en) Use of fatty acid analogues